Larger organ size caused by obesity is a mechanism for higher cancer risk.
H. Grant, Y. Zhang, L. Li, Y. Wang, S. Kawamoto, S. Penisson, D. F. Fouladi, S. Shayesteh, A. Blanco, S. Ghandili, E. Zinreich, J. S. Graves, S. Park, S. Kern, J. Hooper, A. L. Yuille, E. K. Fishman, L. Chu, C. Tomasetti
Abstract
Obesity increases significantly cancer risk in various organs. Although this has been recognized for decades, the mechanism through which this happens has never been explained. Here, we show that obese people (BMI [≥]30) have on average 55% (95%CI: 46%-66%), 68% (95%CI: 59%-76%), and 39% (95%CI: 29%-49%) larger kidneys, liver, and pancreas, respectively. We also find a significant linear relationship between the increase in organ volume and the increase in cancer risk (P-value<10-12). These results provide a mechanism explaining why obese individuals have higher cancer risk in several organs: the larger the organ volume the more cells at risk of becoming cancerous. These findings are important for a better understanding of the effects that obesity has on cancer risk and, more generally, for the development of better preventive strategies to limit the mortality caused by obesity.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Chronic obesity does not alter cancer incidence in Tp53R270H/+ mice
Ilaria Panzeri, Zachary Madaj, … John Andrew Pospisilik·Cancer Research CommunicationsPeer-reviewed·May 21, 2026
- Body size and composition and site-specific cancers in UK Biobank: a Mendelian randomisation study
Mathew Kurian Vithayathil, Paul Carter, … Susanna C. Larsson·bioRxiv·Feb 28, 2020
- Cancer risk and sexual conflict as constraints to body size evolution
E. Y. Erten, H. Kokko·bioRxiv·Jan 9, 2021
- Preventing ovariectomy-induced weight gain decreases tumor burden in rodent models of obesity and postmenopausal breast cancer.
E. A. Wellberg, K. A. Corleto, … E. D. Giles·bioRxiv·Oct 18, 2021
- Endogenous insulin contributes to pancreatic cancer development
Anni M.Y. Zhang, Jamie Magrill, … James D. Johnson·bioRxiv·Jan 24, 2019
- Endocrine-exocrine signaling drives obesity-associated pancreatic ductal adenocarcinoma
K. M. Chung, J. Singh, … M. D. Muzumdar·bioRxiv·Sep 26, 2019